Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089960
Status:
COMPLETED
Last Update Posted:
2013-04-29
First Post:
2004-08-18
Brief Title:
Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors GISTs
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
An Open Label Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors GISTs Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
True
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the safety and effectiveness of AMG 706 in patients with advanced GIST
Detailed Description:
Expanded Access Amgen provides expanded access for this clinical trial Contact the Amgen Call Center 866-572-6436 for more information
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None